Adenocarcinoma, Mucinous - 79 Studies Found Recruiting : Gemcitabine Hydrochloride With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer : Ovarian Brenner Tumor Ovarian Carcinosarcoma Ovarian Clear : 2014-03-28 : Drug: Gemcitabine Hydrochloride Completed : TLR8 Agonist VTX-2337 and Pegylated Liposomal Doxorubicin Hydrochloride or Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity Cancer : Malignant Ovarian Mixed Epithelial Tumor Ovarian Brenner Tumor Drug: TLR8 Agonist VTX-2337 Gi Suspended : Granisetron, Aprepitant, and Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy for Stage II, III, or IV Ovarian Cancer : Nausea and Vomiting Ovarian Brenner Tumor Ovarian Clear Ce : 2011-01-11 : Procedure: Adjuvant Therapy An Terminated : Veliparib, Oxaliplatin, and Capecitabine in Treating Patients With Advanced Solid Tumors : Adenocarcinoma of the Pancreas Adenocarcinoma of the Stomach Drug: veliparib Given PO Active, not recruiting : Bevacizumab and Intravenous or Intraperitoneal Chemotherapy in Treating Patients With Stage II-III Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer : Malignant Ovarian Mixed Epithelial Tumor Ovarian Brenner Tumor Biological: Bevacizumab Given Active, not recruiting : Denileukin Diftitox Used in Treating Patients With Advanced Refractory Ovarian Cancer, Primary Peritoneal Carcinoma, or Epithelial Fallopian Tube Cancer : Fallopian Tube Cancer Ovarian Clear Cell Cystadenocarcinoma Biological: denileukin diftitox Completed : Erlotinib Plus Carboplatin and Paclitaxel in Ovarian Carcinoma : Brenner Tumor Fallopian Tube Cancer Ovarian Clear Cell Cys : 2003-05-06 : Drug: paclitaxel Given IV Completed : Paclitaxel, Cisplatin, and Topotecan With or Without Filgrastim in Treating Patients With Newly Diagnosed Stage III or Stage IV Epithelial Ovarian Cancer : Brenner Tumor Ovarian Clear Cell Cystadenocarcinoma Ovaria : 1999-11-01 : Drug: paclitaxel Given IV Recruiting : TORC1/2 Inhibitor MLN0128 and Bevacizumab in Treating Patients With Recurrent Glioblastoma or Advanced Solid Tumors : Adult Glioblastoma Endometrial Clear Cell Adenocarcinoma E : 2014-05-16 : Biological: Bevacizumab Given Completed : Belinostat and Carboplatin in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer That Did Not Respond to Carboplatin or Cisplatin : Brenner Tumor Fallopian Tube Cancer Ovarian Clear Cell Cys : 2009-10-09 : Drug: belinostat Given IV <<< Previous | Next >>>